Segment, Customer and Geographical Reporting (Tables)

3 Months Ended

Dec. 31, 2016

The Company’s segment information for the three months ended December 31, 2016 and 2015 is summarized below:

Results of Operations for the Three Months Ended December 31,
2016
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	4,405,000		$	4,738,000		$	-	$	9,143,000
Gross profit		1,574,000			1,951,000			-		3,525,000
GM %		36	%		41	%		-		39	%
SG&A		1,328,000			1,740,000			381,000		3,449,000
Operating income (loss)		246,000			211,000			(381,000)		76,000

Depreciation and amortization		234,000			74,000			3,000		311,000
Capital expenditures		91,000			-			20,000		111,000

Intangibles, net		474,000			222,000			337,000		1,033,000
Goodwill		883,000			4,939,000			-		5,822,000
Total assets	$	18,785,000		$	8,407,000		$	1,060,000	$	28,252,000

Results of Operations for the Three Months Ended December 31,
2015
				Contract
	Optics			Research			Biomedical		Total
Revenue	$	6,214,000		$	4,990,000		$	-	$	11,204,000
Gross profit		2,110,000			1,855,000			-		3,965,000
GM %		34	%		37	%		-		35	%
SG&A		1,751,000			1,706,000			348,000		3,805,000
Gain on sale of assets		4,000			-			-		4,000
Operating income (loss)		363,000			149,000			(348,000)		164,000

Depreciation and amortization		228,000			80,000			17,000		325,000
Capital expenditures		565,000			7,000			31,000		603,000

Intangibles, net		644,000			256,000			297,000		1,197,000
Goodwill		1,155,000			4,939,000			-		6,094,000
Total assets	$	16,506,000		$	8,273,000		$	857,000	$	25,636,000

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2016 and 2015 are as follows: